Stereotactic Radiosurgery (SRS)
Stereotactic Radiosurgery (SRS) is a radiation therapy with 20 clinical trials. Currently 5 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
61.5%
8 of 13 finished
38.5%
5 ended early
5
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Clinical Trials (20)
Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases
Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial
A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
Radiosurgery for Patients Recurrent Oligometastatic Disease
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence
Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
SRS (Stereotactic Radiosurgery) Plus Ipilimumab
Radiosurgery and Avastin for Recurrent Malignant Gliomas
Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)
All 20 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 20